Skip to main content

Sharps Technology Advances Shipment Under $50 Million SoloGard Supply Agreement and Begins Manufacturing Facility Upgrades

Second commercial delivery underway as part of multi-year contract with leading U.S. healthcare partner Strategic manufacturing upgrades drive scalability, efficiency, and increases capacity to support production growth NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart safety syringe products to the healthcare industry, today announced an update on the execution of its first shipments under the previously announced $50 million SoloGard sales agreement, alongside a series of advanced manufacturing upgrades. Sharps has initiated the second shipment of its first commercial order of SoloGard syringes under a multi-year supply agreement with a U.S.-based leader in IV flushing...

Continue reading

A.I.S. Resources Closes Shares for Debt Transaction

VANCOUVER, British Columbia, June 18, 2025 (GLOBE NEWSWIRE) — A.I.S. Resources Limited (TSXV: AIS, OTC- PINK: AISSF) (“AIS” or the “Company”) announces that further to the Company’s press release dated February 24, 2025 the Company has settled $380,927.75 of debt through the issuance of an aggregate of 7,618,555 common at a deemed price of $0.05 per Common Share (the “Shares for Debt Transaction”). The Company completed the Shares for Debt Transaction to improve its financial position by reducing its existing liabilities. All securities issued in connection with the Shares for Debt Transaction will be subject to a four-month hold period from the closing date under applicable Canadian securities laws. Under the debt settlement 6,429,480 shares were issued to non-arms length parties in settlement of $321,474. The participation...

Continue reading

Form 8.3 – [ALPHA GROUP INTERNATIONAL PLC – 17 06 2025] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ALPHA GROUP INTERNATIONAL PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

ARRAY Technologies to Acquire APA Solar

Advancing ARRAY’s balance of systems strategy with leading engineered foundation solutions and fixed-tilt mounting systemsAdds domestically manufactured engineered foundations and fixed-tilt solutions to product portfolio, expanding addressable market by nearly 40%Enables integrated tracker + foundation system to address challenging soil conditions, which does not require specialized equipment to installExpands U.S. manufacturing capabilities with new Ohio manufacturing facilityTransaction enterprise value of approximately $179 million represents a multiple of 7.6x APA’s trailing 12 months EBITDA excluding 45X creditsExpected to be high-single-digit percentage accretive to Adjusted EPS in year one before synergiesClosing expected in the third quarter of 2025, subject to regulatory approval and customary closing conditionsALBUQUERQUE,...

Continue reading

Crown Crafts to Announce Fourth Quarter and Full Year Fiscal 2025 Results on June 25, 2025

GONZALES, La., June 18, 2025 (GLOBE NEWSWIRE) — Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”) today announced that it intends to release the results of its operations for the fourth quarter and full year of fiscal 2025 before the market opens on Wednesday, June 25, 2025. Olivia W. Elliott, President and Chief Executive Officer, Craig J. Demarest, Vice President and Chief Financial Officer, and Claire K. Spencer, Vice President, will host a teleconference at 8:00 a.m. Central Daylight Time on that day to discuss the Company’s results and answer appropriate questions. Interested individuals may join the teleconference by dialing (844) 861-5504 and asking to join the Crown Crafts, Inc. call. The teleconference can also be accessed in listen-only mode by visiting the Company’s website at www.crowncrafts.com.   The financial...

Continue reading

Huhtamaki signed a EUR 150 million Schuldschein loan agreement

HUHTAMÄKI OYJ PRESS RELEASE 18.6.2025 AT 12:25  Huhtamaki signed a EUR 150 million Schuldschein loan agreement  Huhtamäki Oyj has signed a EUR 150 million freely transferable loan agreement (Schuldschein). The loan is targeted to institutional investors. It is divided into two floating rate and two fixed rate tranches with maturities of 5 and 7 years. Huhtamaki will use the funds for refinancing and general corporate purposes of the Group.  For further information, please contact:  Tom Erander, Vice President, Treasury, tel. +358 10 686 7893  HUHTAMÄKI OYJGroup Communications About Huhtamaki Huhtamaki is a leading global provider of sustainable packaging solutions for consumers around the world. Our innovative products protect on-the-go and on-the-shelf food and beverages, and personal care products, ensuring hygiene and safety, driving...

Continue reading

Interim report Q2 2024/25 – Half year

Roblon A/S reported increased revenue and earnings for the first half of 2024/25 Highlights  In H1 2024/25, consolidated revenue amounted to DKKm 113.0, against DKKm 110.6 in the year-earlier period. The Composite product group generated revenue growth, while the FOC product group’s revenue declined.   Operating profit before depreciation, amortisation and impairment (EBITDA) and before special items for H1 2024/25 was DKKm 26.2 (DKKm 15.1) and operating profit (EBIT) before special items was DKKm 19.0 (DKKm 6.8).  Consolidated revenue was realised at the lower end of the previously guided range, whereas earnings were realised at the upper end of the previously guided range for the first half. The improved earnings were due to a favourable product mix and realised productivity enhancements resulting from investments in production and ongoing...

Continue reading

CNH’s agriculture design excellence recognized with Case IH brand’s Red Dot Product Design win

Case IH Quadtrac 715Case IH Quadtrac 715 Twin Red Dot Award WinCase IH Quadtrac 715Case IH Quadtrac 715 twin Red Dot Award WinCNH’s agriculture design excellence recognized with Case IH brand’s Red Dot Product Design win Basildon, June 18, 2025 CNH (NYSE: CNH) is proud to announce that the 2025 Red Dot Design Awards has recognized our Case IH brand’s Quadtrac 715 tractor in two categories. Red Dot is one of the world’s largest design competitions with over 18,000 entries from 70+ countries recorded for this edition. The Red Dot Label is internationally sought after as a mark of quality for good design. The Case IH Quadtrac 715 was included in both the ‘Commercial Vehicles: Product Design’ and ‘Innovative Design’ categories. The jury panel of design professionals cited its fusion of aesthetics, ergonomics, and innovation...

Continue reading

Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a strategic partnership with Standard Health www.standardhealth.co.uk to support the development of the first-ever Orthopaedic Ambulatory Surgery Centre in the UK. Based in Poole, Dorset, the new centre will offer NHS and private patients access to leading joint repair and replacement technology for conditions such as rotator cuff repair, ACL reconstruction, knee and hip replacements, and foot & ankle/hand & wrist procedures. Standard Health is a clinical healthcare provider, responsible for site development and operation of the facility with Smith+Nephew supplying its innovative portfolio of medical technologies. Standard Health expects to open a further 10 additional UK sites in the following three years and 20 in total by 2030. The new...

Continue reading

Offentliggørelse af prospekt samt formue og investorer for andelsklassen AKL AlphaCura 0/50/100 W i Investeringsforeningen Wealth Invest

Hermed offentliggøres prospekt samt formue og antal investorer for andelsklassen AKL AlphaCura 0/50/100 W, som optages til handel på Nasdaq Copenhagen A/S med første handelsdag 20. juni 2025.Andelsklasse Formue DKK Antal navnenoterede investorerAKL AlphaCura 0/50/100 W   97.291.800 129Hvis der måtte være spørgsmål i relation til ovenstående, kan der rettes henvendelse til direktør i Wealth Fund Partners A/S, Lise Bøgelund Jensen på telefon 3328 2828.  Med venlig hilsen Investeringsforeningen Wealth InvestAttachment2025 06 20 Børsprospekt WI AlphaCura 050100 AKL

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.